These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7220078)

  • 1. Immunological regulation of experimental cutaneous leishmaniasis. 2. Studies with Biozzi high and low responder lines of mice.
    Hale C; Howard JG
    Parasite Immunol; 1981; 3(1):45-55. PubMed ID: 7220078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1980 Sep; 152(3):594-607. PubMed ID: 6447751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice.
    Howard JG; Hale C; Chan-Liew WL
    Parasite Immunol; 1980; 2(4):303-14. PubMed ID: 7220075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.
    Handman E; Ceredig R; Mitchell GF
    Aust J Exp Biol Med Sci; 1979 Feb; 57(1):9-29. PubMed ID: 314286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.
    De Rossell RA; Bray RS; Alexander J
    Parasite Immunol; 1987 Jan; 9(1):105-15. PubMed ID: 3562057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
    Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
    Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blast transformation in different stages of cutaneous leishmaniasis.
    Witztum E; Spira DT; Zuckerman A
    Isr J Med Sci; 1978 Feb; 14(2):244-7. PubMed ID: 649353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.
    Liew FY; Millott S; Lelchuk R; Cobbold S; Waldmann H
    Clin Exp Immunol; 1989 Mar; 75(3):438-43. PubMed ID: 2784747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
    Lelchuk R; Graveley R; Liew FY
    Cell Immunol; 1988 Jan; 111(1):66-76. PubMed ID: 3257416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.
    Mitchell GF; Handman E
    Aust J Exp Biol Med Sci; 1983 Feb; 61(Pt 1):11-25. PubMed ID: 6870673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.
    Preston PM; Dumonde DC
    Clin Exp Immunol; 1976 Jan; 23(1):126-38. PubMed ID: 1261086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.
    Scott P; Sacks D; Sher A
    J Immunol; 1983 Aug; 131(2):966-71. PubMed ID: 6863939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of Biozzi high and low responder mice upon infection with Schistosoma mansoni.
    Blum K; Cioli D
    Eur J Immunol; 1978 Jan; 8(1):52-6. PubMed ID: 565288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nematospiroides dubius: the course of primary, secondary and tertiary infections in high and low responder Biozzi mice.
    Jenkins DC; Carrington TS
    Parasitology; 1981 Apr; 82(Pt 2):311-8. PubMed ID: 7220090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1981 Mar; 153(3):557-68. PubMed ID: 6454739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility and resistance to Leishmania amazonensis in H-2q syngeneic high and low antibody responder mice (Biozzi mice).
    Lima GM; Puel A; Decreusefond C; Bouthillier Y; Mevel JC; Abrahamsohn IA; Mouton D
    Scand J Immunol; 1998 Aug; 48(2):144-51. PubMed ID: 9716105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG; Liew FY
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):87-98. PubMed ID: 6151691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.